Abstract
Eye diseases have a high prevalence and large impact on quality of life. Since dry eye to retinal degenerations, passing through the ocular surface diseases, glaucoma and cataracts, almost all had a substantial increase in knowledge on the epidemiology and pathophysiology in recent decades, and the acquisition of a broad therapeutic arsenal, but often palliative and repeated use. In this …